
    
      Requests for access to the Sponsor must be made by a licensed physician for a specific
      patient, based on a determination with the patient that the benefits of treatment with the
      investigational drug outweigh the risks. Licensed physician's with eligible patients must
      apply and meet requirements for participation in the expanded access program.
    
  